Republic
of the Philippines
Philippine
National AIDS Council
Office of the Philippine National AIDS
Council Secretariat
3rdFlr.
Bldg. 15, Department of Health, San Lazaro Compound,
Rizal Ave., Sta Cruz, Manila
Tel. (632) 743-05-12 Trunkline: 743-83-01 loc. 2551
TITLE
OF TA: Midterm
Review of the 5th AIDS Medium Term Plan (AMTP5)
TYPE
OF TA: Assessment
TA RECIPIENT: Philippine
National AIDS Council (PNAC)
SUGGESTED TA PROVIDER: Consultant – PROGRAM EVALUATION SPECIALIST
1. BACKGROUND
AND RATIONALE
HIV
prevalence in the Philippines remains under 0.1%, but rapidly expanding among
key affected populations (KAP). By 2011,
HIV prevalence rose to 4-6% among males who have sex with males (MSM) in the
cities of Cebu, Quezon and Manila; 53% among people who inject drugs (PWID) and
5% among female sex workers (FSW) in Cebu City. (2012 GARPR)
The
number of cases reported has shown a steep increase in the last 6 years - from
less than 1 case a day in 2006 to 9 cases a day in 2012. As of May 2013, there are already 12 HIV cases
reported per day or 4,400 new cases by the end of 2013. This is likely to increase
every year. In 2012, PNAC has projected that the total number of HIV cases in
the Philippines could reach 37,000, or as high as 54,000 by 2015. Those infected
are young with a median age of 27, with period of initiation to sex and drug
use among key affected populations as
early as 14 years old. Sex is still the
main mode of transmission with 85% of new cases were reportedly through
male-to-male sex in 2012. (2012 Spectrum Projections, 2013 AIDS Registry)
HIV
cases among Overseas Filipino Workers (OFW) continue to increase (43 cases per
month since Jan 2013) despite the decrease in proportion of OFW to the total
cases. This indicates that local transmission has outpaced infections
reportedly contracted overseas. (2013 AIDS Registry)
The
Philippines was categorized as one of the countries with the lowest level (less
than 25%) of coverage of prevention programs among MSM and HIV testing among
MSM and PWID. Very few KAPs were tested for HIV (merely 14%) and zero for key
affected populations under the age of 18 (2012 GARPR).
While
substantial increase in the ART coverage and high ART retention were
documented, PMTCT leaves a large room for improvement.
The
2012 Philippine MDG Report to the UN regards MDG 6, particularly HIV, as among
the MDG targets that are least likely to be achieved. The Global Fund, who had
the largest investment on HIV in the Philippines since 2004, concludes that,
given the available information, Philippines' national program currently stands
at "limited progress toward impact”. Current strategies to reach
KAP, particularly MSM and PWID, should be revised to reverse the current
increase in HIV incidence and prevalence.
Given
these, and as planned, PNAC will review AMTP5at midterm, in collaboration with
UNAIDS and WHO, an external team of consultants will be convened to determine
the magnitude of the country’s HIV epidemic and assess the current achievement
of the AMTP5 in terms of the coverage and quality of interventions and the
efficiency of interventions in terms of availability, accessibility and
delivery in achieving the outcome and impact.
As
part of the review, the Department of Health (DOH), with support from WHO, will
support another team of consultants (but part of the AMTP5 midterm review team)
to assess the Health Sector HIV response including key components of the
National AIDS/STI Prevention and Control Program (NASPCP).
2. OBJECTIVES
The main objectives of the midterm review
is to assess the country’s HIV epidemic and the first 3 years of AMTP5
implementation (2011-2013). In particular, the review aims to:
a) To determine the HIV burden in the country over the past decade (covering
both AMTP4 and AMTP5) in terms of incidence, prevalence and mortality and its
variation by demographic (e.g. age and gender), geographic, and socioeconomic
characteristics.
b) To assess progress towards achievement of AMTP5 targets per output (by
strategic objective);
c) To determine investments into AMTP5 both at national and local levels and
assess whether these investments address sufficiently the resource requirements
of AMTP5;
d) To determine whether AMTP5 has been implemented in a multisectoral manner
i.e. it includes achievements in both health and non-health sectors. The health
sector will include particular assessments of HIV counseling and testing, ART
for and care of PLHIV, and STI management among key populations;
e) To determine programmatic and policy issues that facilitated and hindered
the achievements of AMTP5 targets
f) To determine the efficiency of the HIV monitoring, evaluation and
information system in the country particularly up-to-date projection of HIV
incidence, prevalence and mortality; timely publication of the surveillance/
IHBSS reports; reporting on prevention programs among MSM and PWID; reporting
ART;
PNAC expressed that, out of the midterm
review, key recommendations on strategic priorities for 2014-2016 will be
developed, highlighting lessons learned and specifying ways for PNAC to
redirect AMTP5 particularly in updating its Investment Plan. PNAC also wishes
that the review will look into the High Level Meeting (HLM) targets set by ASEAN
countries.
3. SCOPE
OF WORK, DELIVERABLES and TIMELINE
An external
team of consultants will be convened to conduct the AMTP5 midterm review. These will be composed of the following:
a)
Overall Team Leader (Evaluation Specialist - to
be supported by UNAIDS, see separate TOR)
b)
Program Evaluation Specialist (to be supported by
UNAIDS)
c)
Impact Evaluation Specialist (online support
during preparatory phase thru Global Fund)
d)
Health Sector Assessment Team (to be supported by
WHO)
i.
Team Leader
ii.
Two (2) Programme Specialists
iii.
Monitoring and Evaluation Specialist
e)
A team of data collectors (4 research assistants)
(to be supported by DOH–NEC)
This TOR assumes that the team will be
grouped into 2-3 sub-teams for data collection and will travel to 9-10
sites/cities around the country (3-4 in Luzon, 3 in Visayas and 3 in Mindanao).
Selected cities in Metro Manila and Cebu will also be visited.
The team will ensure conduct of the following:
Phase
|
Scope
of Work
|
Deliverables
|
Timeline
|
Background review and preparatory phase
|
a)
Determine scope of the AMTP5 Midterm Review, in consultation with
DOH-WHO Health Sector Assessment Team Leader and Global Fund Impact
Evaluation Specialist
b)
Development of
assessment framework, plan, and tools
c)
Background document,
desk review
d)
Conduct of
consultative meetings with stakeholders and assessment team
e)
Orientation on data
collection activities
|
Inception
Report
Assessment
Tools
|
10 days
- within September 1 and
October 2, 2013
|
Data Collection Phase
|
f)
Site visits
(depending on the assessment plan). Tentatively
- 4 days Metro Manila
- 3 days Luzon (e.g. Baguio or Angeles)
- 3 days Visayas (e.g. Cebu)
- 3 days Mindanao (e.g. Davao)
g) Debriefing
with PNAC and stakeholders and submission of the Interim Report
|
Interim
Report
|
13 days
- within October 3-28,
2013
|
Analysis and report writing phase
|
h)
Analysis and report
preparation
i)
Discussion of key
findings with PNAC and other stakeholders
j)
Revisions
k)
Submission of the
final report
|
Final
AMTP5 Midterm Review Report
|
10 days
– within October 29 and November
15, 2013
|
|
TOTAL Consultancy Days
|
|
33 days
|
4. DURATION
The PROGRAM EVALUATION SPECIALIST will assist the
Overall TEAM LEADER and will be hired for 33 days spread between September 1 and November 15, 2013:
a)
Background review and preparatory
phase: 10 consultancy days
b)
Data Collection Phase:
13 consultancy days
c)
Analysis and report writing phase: 10
consultancy days
5. SITES
Nationwide – including key cities in Metro Manila
and around 9-10 cities around the country (3-4 in
Luzon, 3 in Visayas and 3 in Mindanao). But will depend widely on the
assessment framework and plan.
6. TYPE
OF PROVIDER
Consultant
– PROGRAM EVALUATION SPECIALIST
7.
SKILLS and QUALIFICATIONS
Expected
Qualifications
a)
At least 5 years of experience in HIV program
evaluation, especially in low prevalence or concentrated epidemics. Has
conducted at least 3 similar/related consultancies
b)
At least 5 years of experience working in the area
of HIV and AIDS particularly in local governance or local HIV response
c)
Experience with both quantitative and qualitative
methods of data collection and analysis
d)
Experienced
in dealing with various sectors such as government, civil society, etc.
e)
Preferably
based in the Philippines
Expected
skills
a)
Excellent verbal and written communication skills
b)
Keen eye for details
c)
Systematic,
highly organized, able to translate complicated and technical concepts into
easily understood forms
d)
Good
interpersonal skills
8.
SCHEDULE OF PAYMENTS
Payment
|
Description
|
Deliverable
Requirements
|
1stPayment
|
75%
advance of DSA
|
Signed
Contract
|
2ndPayment
|
30
% of consultancy fees
|
Upon submission and satisfactory
acceptance of Inception Report and
Assessment Tools by the PNAC Executive
Committee
- by email
|
3rdPayment
|
30%
of consultancy fees
|
Upon submission and satisfactory
acceptance of Interim Report by the
PNAC Executive Committee - by email
|
Final
Payment
|
40
% of consultancy fees
25%
of DSA
|
Upon
assignment completion with:
·
All deliverables
especially submission
of Final AMTP5 Midterm Review Report
·
Written approval by PNAC Secretariat
Director that the assignment is complete and satisfactory
|
9.
REPORTING PRACTICE
The consultant shall:
a) Shall
directly report to the PNAC Secretariat Director, with all communications
copied to the focal persons of PNAC and UNAIDS
b) Shall
perform the services and carry out the deliverables with all diligence,
efficiency and economy in accordance with general accepted professional
techniques and practices
c) Shall
observe sound management practices and employ appropriate advance technology
and safe methods
d) Abide
by terms and conditions stipulated by the contract
10. Immediate Requirement from the Consultant
Submit
the following by close of business on Friday, July 26, 2013 to flavelino58@gmail.com and cc to jojorfeliciano@gmail.com and mosendez@unaids.org.
a)
Letter of interest – This should explain why s/he
is the most suitable person to perform the work and deliver the outputs.
b)
Personal CV – This should highlight past
experiences in similar projects/assignments and indicating at least 3
references
c)
At least one sample evaluation report
Signatory
/ Manager
|
Focal Persons
|
Dir. Ferchito Avelino
Director
III
PNAC Secretariat
Department of Health
San Lazaro Compound,
Manila, Philippines
Email: flavelino58@gmail.com
Phone:
+63-2-743-0512
|
Dr.
Joselito Feliciano
M&E Officer
PNAC Secretariat
Department of Health
San Lazaro Compound,
Manila, Philippines
Email: jojorfeliciano@gmail.com
Phone:
+63-2-743-0512
Mr. Zimmbodilion
Mosende
Strategic
Information Adviser
UNAIDS
Philippines
Email:
mosendez@unaids.org
Phone: +63-2-901-0413
|
ANNEXES
Annex A. IMPLEMENTATION
ARRANGEMENTS
1. Representatives
and Contract Administration Arrangement for AMTP5 Midterm Review (from herein
will be referred to as the “Project”)
1.1. The
PNAC Executive Committee will be the designated Project Management Committee
(PMC) while the PNAC 5th AMTP Review Technical Working Group (TWG)
which is composed of official representatives from the Department of Health (DOH),
Department of Local and Interior Government (DILG), National Economic
Development Authority (NEDA), Department of Labor and Employment(DOLE),
Department of Social Welfare and Development (DSWD), Action for Health
Initiatives (ACHIEVE) and Pinoy Plus.
1.2. The
PMC appoints Dr. Ferchito L. Avelino as the PNAC Project Manager (PM). The PM
has the authority to represent the PNAC on all day to day matters relating to
the project or arising from the contract. All notices, instructions, orders,
certificates, approvals and all other communications under the contract shall
be communicated to the PNAC through the PM except otherwise stated in the
contract.
1.3. Policies,
issues and concerns affecting the AMTP5 midterm review shall be coursed through
the PM who shall ensure that the PNAC TWG resolves the issue within reasonable
time.
2. Reporting
Obligations and Approval Process
2.1. Reports
are based on expected scope of work and deliverables
2.2. All
reports shall be submitted to the PNAC TWG for review and comments, through the
PM
2.3. Approvals
of the final products shall be done by the PNAC (Executive Committee)
2.4. Any
documents shall not be disapproved except on the grounds that the document does
not comply with the specified provision of the TOR and contract or that, it is
contrary to good industry practice.
2.5. If
the output is disapproved by the PNAC, the Consultant shall modify the output
and resubmit it for approval. If the modifications required had been made, then
it shall deem to have been approved unless such modification that has been
agreed upon has not been done.
3. Roles
and responsibilities Agencies involved in the project
3.1. Consultants
3.1.1. The
UNAIDS hired consultants will be the overall TEAM LEADER for the AMTP5 Midterm
Review and to be supported by a PROGRAM EVALUATION SPECIALIST.
3.1.2. The
consultants shall perform the services and carry out their obligations with all
assiduousness, efficiency and economy in accordance with generally accepted
professional techniques and practices and shall observe sound management
practices and employ appropriate advance technology and safe methods.
3.1.3. Conduct
all activities with due care and diligence, in accordance to the TOR and the
contract and with the skill and care expected of a competent provider of the
technical services required.
3.1.4. Shall
provide as needed sufficient properly qualified operating and technical
personnel to properly carry out the project at or before the time specified in
this TOR.
3.1.5. Always
act in respect of any matter relating to the contract or Services as the
faithful advisers and technical provider to the PNAC. It shall at all times
support and safeguard the PNAC’s and governments legitimate interest in any
dealing with third party.
3.2.
PNAC Secretariat
3.2.1. Shall be responsible in the coordination of members of the midterm
review team, venues and food for the respondents and partner agencies who will
be involved.
3.2.2. Shall be responsible for the plane fares of the midterm review
team.
3.2.3. Be responsible for the timely provision of all the resources,
access, information and decision making under its control necessary for the
project as identified agreed and finalized project plan, except where provision
of such item is explicitly identified in the contract as being the
responsibility of the consultant
3.2.4. Ensure
accuracy of all PNAC information and data to be supplied to the Consultants
3.2.5. Issue
the acceptance report of deliverables
3.2.6. Identify
control points or milestones or submission or outputs of the Consultants. These
outputs are to be reviewed and will indicate whether the project should proceed
or not or to take other options toward project completion.
3.2.7. Shall
provide per diem to the six (4) research assistants during data collection.
3.3. DOH-NASPCP
3.3.1. Shall
select and hire the consultants/members of the Health Sector Assessment Team
3.3.2. Shall
pay for the consultants fee of the Health Sector Assessment Team
3.3.3. Shall
provide for four (4) research assistants to assist the evaluation team in data
gathering. (DOH-NEC will be providing for their salaries only)
3.4. UNAIDS
3.4.1. Shall
shoulder the consultants’ fee and DSA of the overall TEAM LEADER and PROGRAM
EVALUATION SPECIALIST for conducting the AMTP5 midterm review (excluding Health
Sector Assessment Team).
3.5. WHO
3.5.1. Shall
shoulder the consultants’ fee of Health Sector Assessment Team who are hired/selected
by DOH-NASPCP).
3.6. GLOBAL
FUND
3.6.1. Shall
appoint an Impact Evaluation Specialist who will provide online technical support
to the AMTP5 Midterm Review Team.
Annex B: CONCEPT
NOTE
National Health Sector HIV Programme Review and Development of a
National M&E Plan: The Philippines
(Concept note, 6 June, 2013)
1. Background
The Philippines is still a low HIV prevalence country, but the epidemic
is increasing very rapidly in the past five years. The number of HIV cases
reported has increased from one every three days in year 2000, to one
within three hours by the end of 2012 . HIV
transmissions are mostly concentrated among males who have sex with males (MSM)
and people who inject drugs (PWID) in certain geographic areas. From 1984 to
the end of 2012, there were 11,702 diagnosed HIV cases reported to the
Philippine HIV & AIDS Registry. Among the reported cases, 86% were
males. Majority (62%) of the reported
cases in 2011 were 21-30 years. It is estimated that 23922 people are living
with HIV by 2012.
Progress has been made in terms of prevention and access to
antiretroviral therapy (ART). Prevention focuses on targeted education,
risk-reduction counselling and condom promotion by health workers and their
trained volunteer peer educators in high risk areas. The GFATM Projects have
been instrumental in the institutionalization of provision of ART. From 2004
(Round 3) until January 2012, the cumulative number of PLHIV enrolled to ART is
2,087 representing approximately 90% of those who are in need of treatment.
From 6 treatment hubs in 2004, Department of Health (DOH) has expanded ARV
services to 16 Treatment Hubs in the country. One important measure in ensuring
continuous access to treatment, care and support services of PLHIV is the
provision of medical and financial support through the Philhealth Outpatient
HIV and AIDS Treatment (OHAT) Package amounting to Php 30,000 per patient per
year to cover for drugs and medicines, laboratory examinations including CD4
and viral load determination, and professional fees of service providers.
Important challenges facing the HIV response in the Philippines include:
stigma and discrimination to people living with HIV and key populations, long
waiting time before HIV test results are given, high rate of lost to follow-up
after being tested positive, insufficient coverage of interventions with key
population, MSM and PWID in particular, insufficient resources and capacity,
particularly for surveillance, monitoring and evaluation, as well as the need
to rapidly scale up effective interventions such as testing and counselling to
key populations, and harm reduction programme to people who inject drugs in
some geographic areas.
The Department of Health (DOH), through the Philippine National AIDS
Council (PNAC) has come up with the 5th AIDS Medium Term Plan 2011 –
2016 (AMTP) to address the HIV and AIDS situation in the country. This is in
conjunction with the Medium Term Philippine Development Plan (MTPDP) in order
to achieve the Millennium Development Goals (MDG). The 5th AMTP
provides the overall direction of the implementation of the programs and projects
on HIV and AIDS in the Philippines. The 5th AMTP has started its
implementation in 2011 and will end by 2016. As AMTP5 reached halfway of its
implementation, an external evaluation is needed. The evaluation will focus on
the five strategic objectives of the 5th AMTP assessing the status
of its implementation. The assessment would also inform the Philippine National
AIDS Council (PNAC) priority actions in the second half of the 5th AMTP.
As part of the overall evaluation of the 5th AMTP led by PNAC,
the DOH is requested to take the lead in the health sector HIV programme
review, which would focus on HIV testing and counselling, treatment and care,
sexually transmitted infections (STI) among key populations, as well as the
monitoring and evaluation of the health sector response, leading to develop a
National M&E Plan.
2. Purpose and objectives
The purpose is to assess the progress and quality implementation of the
first three years of the 5th AIDS Mid Term Plan 2011-2016, and
evaluation of the implementation of the National Health Sector HIV Strategic
Plan 2008-2012. The findings and recommendations of the review will be used to
inform the implementation of the remaining years of the 5th AMTP,
and the adjustment/revision of the National Health Sector HIV Strategic Plan
2013-2016, which has just been drafted. The assessment of the monitoring and
evaluation system will inform the development of the National HIV M&E Plan.
Specific
objectives:
•
To assess progress of the health sector
response to HIV in terms of coverage, effectiveness, impact and quality of
services, with special focus on HIV testing and counseling, treatment and care,
and STI prevention and control among key populations.
•
To identifying gaps and constraints and
provide recommendations scaling up key health sector responses to HIV, in
particular HIV testing and counseling, treatment and care and STI prevention
and control among key populations.
•
To assess the health sector HIV
strategic information system, including surveillance, monitoring and evaluation
system, and develop a health sector HIV programme M&E plan.
3. Scope and process
3.1 The review should cover the following:
•
The status, trends, dynamics of HIV/AIDS and other STI infections
•
An analysis of the performance of current interventions/services,
achievements, obstacles and gaps in response;
•
An assessment of links to other programmes (TB, RH, workplace such as
call centers, etc.)
•
Identification of the leading issues and constraints facing the
programmes on HIV and STI
•
A gap analysis and recommendations for improving the national health
sector response to HIV
•
For assessment of the M&E system:
o
Assessment of the existing health
sector’s monitoring and evaluation system, including infrastructure, manpower
capacity, technology, resources, policies
o
Harmonization of the reporting systems,
indicators, reports within the HIV program, and with other programs like TB,
MCH, and universal health care (eg. FHSIS, KP dashboard)
o
Develop a 5 year health sector M&E
costed plan, with the purpose of improving the quality, accuracy, timeliness,
completeness and availability of information; increasing the utility of
existing data at national and sub-national levels, triangulating data, and disseminating information
3.2 Following activities are expected
to be carried out:
•
Desk review (policy and programme documents, progress reports, project
proposals survey and research reports, evaluation reports, media reports and
other data sources. A check list of documents and related information will be
provided in advance by WHO Philippines)
•
Technical briefing by the National HIV programme about epidemiological
situation, programme priorities, interventions, achievements, challenges and
future perspectives
•
Interviews with key stakeholders (government institutions,
non-government, civil society, clients of STIs, HIV and AIDS services, PLHIV,
sex workers, MSM population, UN agencies, researchers, private sector)
•
Group discussions (care providers, populations at risk, young people at
higher risk including staff from call centers)
•
Site visits to organizations and institutions implementing HIV/AIDS and
STIs prevention, treatment, care or support programmes or services
•
Stakeholder meetings
•
Dissemination workshop of the draft review report
•
Holding a press conference to share the major findings and
recommendations and
•
Submission of the final report within one month after the mission.
4. Deliverables
•
Summary of preliminary findings and recommendations to the national
counterparts at the end of the mission.
•
A comprehensive programme review report in both hardcopy and electronic
form. The report should clearly identify the achievements and strengths,
weaknesses, gaps, and challenges, and make recommendations for consolidating
and improving programme effectiveness.
•
An assessment report of the National M&E system, against the Global
Fund M&E guide;
•
A draft National Health Sector M&E Plan, which is costed.
5. Organization
The review will be coordinated by the National HIV Programme, DOH of the
Philippines. External and internal consultants will be recruited to work with
the programme managers and staff. WHO Country Office in the Philippines and the
WHO Regional Office for the Western Pacific will provide necessary technical
and financial support to conduct the review.
6. Consultants
A team of 6-8 consultants (3-4 international and 3-4 local) will be
recruited. A team leader will be appointed among the consultant to lead the
review. They will be funded by WHO.
The international consultants should be leading experts working in the
areas of HIV testing and counselling, antiretroviral therapy and STI, with rich
international experiences, particularly in the low and concentrated Asia
epidemic settings. S/he should have experiences for programme review and
assessments, and with good track records working with governments and agencies.
The local consultants are national experts in the areas of health
programme implementation and management, with experiences of data collection,
collation and analysis. They should have training on health sciences related
disciplines, with master degree of public health or epidemiology. S/he should
be able to work with the international teams to provide data collection,
encoding and analysis, conduct the field survey and provide other inputs as
necessary.
7. Timeline
In consultation with the National AIDS Programme, and in consideration
of the overall timeline of the 5th ATMP evaluation, the following
timeline is proposed for the health sector HIV programme review and M&E
plan development.
Scope
of Work
|
Deliverables
|
Timelines
|
Responsible
|
Convening the panel of experts/consultants
|
4 research assistants recruited (funded by
DOH-NEC)
4 international consultants recruited (funded by
WPRO)
|
Aug. 2013
Aug. 2013
|
DOH
WHO
|
Development of review plan, methodologies and
tools; background documents and data collection and review - preparation
phase
|
Review plan, methods and tools, initial desk
review
|
1 - 30 Sep., 2013
|
Research assistants working with DOH,
international consultants and WHO. Team Leader of health sector review to
discuss and harmonize with overall team leader.
|
Joint thematic programme review through desk
review, interviews, focus group discussions, site visits, and others
|
Joint programme review done with three thematic
teams: HTC/ART, STI, Strategic Information (SI); Interim report submitted by
the end of the mission
|
Oct. 2013.
The site visit takes place on 14-24 Oct
|
Consultants working with the DOH and WHO.
|
Report writing, discussions and revisions, and
submission of the final report
|
Final report
|
25-31 Oct. 2013
|
Consultant team, led by team leader, with inputs
from Overall Team Leader
|
AMTP5 Final Report writing and submission
|
Inputs to the AMTP5 Final report
|
15 Nov. 2013
|
Consultant team, led by team leader, coordinated
with Overall Team Leader
|
8. Contacts
Dr Jose Gerard B. BELIMAC
Medical Specialist II
National Center for Disease Prevention and Control
Infections Disease Office
Building 19, Department of Health, Sta. Cruz
Manila, the Philippines
Tel No. : (632) 495 0149
E-mail : naspcp@yahoo.com
Dr Zhao Pengfei (Act as interim focal point for WHO Country Office in
the Philippines) and Dr. Yu Dongbao (act as focal point for WHO WPRO)
World Health Organization Regional Office for the Western Pacific
UN Ave.
Manila 1000,
The Philippines
.JPG)
.jpg)
.jpg)
